Citius Pharmaceuticals Inc (CTXR)

1.370 +0.050 (+3.79%)
Closed USD Disclaimer
1.380 +0.010 (+0.730%)

Citius Pharmaceuticals Inc Company Profile

Equity Type
Citius Pharmaceuticals Inc. specialty pharmaceutical company. The Company develops and commercializes critical care products with a focus on anti-infective products in adjunct cancer care, prescription products and mesenchymal stem cell therapy. It has five products: Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. Mino-Wrap is a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries. Halo-Lido is a corticosteroid-lidocaine topical formulation, which is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids. NoveCite is a mesenchymal stem cell therapy for the treatment of ARDS. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma.
Contact Information
Cranford,07016 United States
908 967 6677
Top Executives
Perenlei Enkhbaatar 0 0000 ARDS Scientific Advisory Board Member
Carol A. Webb 74 2016 Independent Director
William J. Kane 77 2016 Independent Director
Issam Raad 0 0000 Chairman of Scientific Advisory Board
Mark Rupp 0 0000 Member of Scientific Advisory Board
Howard Safir 77 2016 Lead Independent Director
Eugene Holuka 62 2016 Independent Director
Suren G. Dutia 78 2015 Independent Director
George M. Viola 0 0000 Member of Scientific Advisory Board
Leonard A. Mermel 0 2018 Member of Scientific Advisory Board
Jesse C. Selber 0 0000 Member of Scientific Advisory Board
Mitchell M. Levy 0 0000 ARDS Scientific Advisory Board Member
Lorraine B. Ware 0 0000 ARDS Scientific Advisory Board Member
Michael A. Matthay 0 0000 ARDS Scientific Advisory Board Member
John Laffey 0 2021 ARDS Scientific Advisory Board Member
Joel Rosenblatt 0 0000 Member of Scientific Advisory Board
Leonard L. Mazur 77 2014 Co-Founder, CEO, Chairman & Secretary
Myron Z. Holubiak 75 2015 Co-Founder & Executive Vice Chairman
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.